FDA lifts restrictions on Glaxo diabetes drug Avandia

FDA lifts restrictions on Glaxo diabetes drug Avandia

GlaxoSmithKline could not immediately be reached to comment on the FDA decision. But the British drugmaker had previously said it was not likely to put its marketing muscle behind Avandia again, even if the FDA were to lift usage restrictions. Its U.S

7
Like
Save

Comments

Write a comment

*